The Eurotherm3235Trial is an international, multi-centre, randomised controlled trial which will examine the effects of titrated therapeutic hypothermia (32-35°C) as a treatment for raised intracranial pressure after traumatic brain injury. Professor Peter Andrew discusses the Eurotherm3235 Trial and his role as Chief Investigator. HTML Funding provided by: Aug 2012 - The Eurotherm3235 Trial is funded by the National Institute of Health Research's Health Technology Assessment Programme - www.nihr.ac.uk The internal pilot was funded by the European Society of Intensive Care Medicine – www.esicm.org Trial Sponsor: University of Edinburgh and NHS Lothian (UK) This article was published on 2024-09-24
